Literature DB >> 2594595

Effect of treatment with botulinum toxin on spasticity.

T K Das1, D M Park.   

Abstract

Botulinum toxin, a product of Clostridium botulinum, produces presynaptic neuromuscular block by preventing release of acetylcholine from nerve endings. The toxin was injected directly into the skeletal muscles of six patients with severe spasticity due to stroke-related hemiplegia. It produced both subjective and objective improvement. The toxin injections were well tolerated and no significant side effect was reported.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2594595      PMCID: PMC2429289          DOI: 10.1136/pgmj.65.762.208

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  10 in total

1.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

Authors:  F I MAHONEY; D W BARTHEL
Journal:  Md State Med J       Date:  1965-02

2.  Grading of spasticity and its effect on voluntary movement.

Authors:  B Goff
Journal:  Physiotherapy       Date:  1976-11       Impact factor: 3.358

3.  Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.

Authors:  M F Brin; S Fahn; C Moskowitz; A Friedman; H M Shale; P E Greene; A Blitzer; T List; D Lange; R E Lovelace
Journal:  Adv Neurol       Date:  1988

4.  Editorial: Spasticity: the fable of a neurological demon and the emperor's new therapy.

Authors:  W M Landau
Journal:  Arch Neurol       Date:  1974-10

5.  Double-blind study of botulinum toxin in spasmodic torticollis.

Authors:  J K Tsui; A Eisen; A J Stoessl; S Calne; D B Calne
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

6.  Botulinum toxin: mechanism of presynaptic blockade.

Authors:  I Kao; D B Drachman; D L Price
Journal:  Science       Date:  1976-09-24       Impact factor: 47.728

7.  Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.

Authors:  A B Scott
Journal:  Ophthalmology       Date:  1980-10       Impact factor: 12.079

8.  Stroke rehabilitation: analysis of repeated Barthel index measures.

Authors:  C V Granger; L S Dewis; N C Peters; C C Sherwood; J E Barrett
Journal:  Arch Phys Med Rehabil       Date:  1979-01       Impact factor: 3.966

9.  Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections.

Authors:  J S Elston
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

10.  Effect of treatment with botulinum toxin on neurogenic blepharospasm.

Authors:  J S Elston; R W Russell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22
  10 in total
  18 in total

1.  Evaluating the role of botulinum toxin in the management of focal hypertonia in adults.

Authors:  D Richardson; G Sheean; D Werring; M Desai; S Edwards; R Greenwood; A Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

Review 2.  Spasticity after stroke. Epidemiology and optimal treatment.

Authors:  C F O'Brien; L C Seeberger; D B Smith
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

3.  Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.

Authors:  B B Bhakta; J A Cozens; M A Chamberlain; J M Bamford
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

4.  Use of botulinum toxin in stroke patients with severe upper limb spasticity.

Authors:  B B Bhakta; J A Cozens; J M Bamford; M A Chamberlain
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

5.  Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.

Authors:  N Hyman; M Barnes; B Bhakta; A Cozens; M Bakheit; B Kreczy-Kleedorfer; W Poewe; J Wissel; P Bain; S Glickman; A Sayer; A Richardson; C Dott
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

6.  Assessing the immediate impact of botulinum toxin injection on impedance of spastic muscle.

Authors:  Xiaoyan Li; Henry Shin; Le Li; Elaine Magat; Sheng Li; Ping Zhou
Journal:  Med Eng Phys       Date:  2017-02-04       Impact factor: 2.242

Review 7.  Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity.

Authors:  Andrea Santamato; Francesco Panza
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

8.  Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.

Authors:  G L Sheean; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

9.  Treatment of overactive bladder with botulinum toxin type B: a pilot study.

Authors:  Dennis Dykstra; Al Enriquez; Michael Valley
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-11-25

10.  Renal Sympathetic Denervation - A Review of Applications in Current Practice.

Authors:  Vikas Kapil; Ajay K Jain; Melvin D Lobo
Journal:  Interv Cardiol       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.